Stockreport

Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term Profitability [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF Expects to finish 2024 with $65 million or more in cash and cash equivalents Withdraws formal revenue guidance due to recent growth headwind from U.S. FDA's late-Q3 2 [Read more]